
-
Australia recall O'Connor to face champions South Africa
-
Kremlin says Putin, Trump to hold 'one-on-one' talks in Alaska
-
Stocks diverge as bitcoin hits record high
-
Spain suffers third wildfire death, Greece beats back flames
-
Liverpool 'agree deal' for Parma prospect Leoni
-
Foreign NGOs say new Israeli rules keep them from delivering Gaza aid
-
Japan's grand tea master Sen Genshitsu dies at 102: reports
-
Water shortages plague Beirut as low rainfall compounds woes
-
Germany's Thyssenkrupp cuts targets as US tariffs weigh
-
UK PM hosts Zelensky in London on eve of US-Russia summit
-
Brady didn't understand football, says Rooney after 'work ethic' jibe
-
Greek firefighters make progress against wildfires
-
UK economy slows less than feared after tariffs
-
Markets mixed as bitcoin hits new high
-
PSG begin French title defence as Pogba returns home and Paris FC step up
-
At least 40 dead in Sudan's worst cholera outbreak in years: MSF
-
Zelensky in London to meet PM ahead of US-Russia summit
-
French dictionary gets bad rap over Congolese banana leaf dish
-
Alaska: a source of Russian imperial nostalgia
-
Last chance saloon for global plastic pollution treaty
-
India to bid for Commonwealth Games as part of Olympic push
-
North Korea denies removing border loudspeakers
-
Despite risks, residents fight to protect Russian national park
-
Asian markets mixed as bitcoin surges to new high
-
War-weary Ukrainians find solace by frontline lake
-
Okinawa a reluctant host for US troops 80 years after WWII
-
Alonso's Real Madrid start La Liga with fresh energy
-
Liverpool splash out to secure status as Premier League's top dogs
-
Hong Kong court postpones closing arguments in Jimmy Lai trial
-
Top Japanese fighter retires to support comatose boxer brother
-
Boars, Butterflies or Bees? Public to name Papua New Guinea's NRL team
-
Defending champions Sinner, Sabalenka reach Cincinnati quarters
-
Bolivia presidential hopefuls make last push for votes
-
Trump orders space regulations eased in win for Musk
-
Trump warns of make-or-break chance with Putin as pressure mounts
-
From Snoop Dogg to Tom Brady, stars flock to English second-tier clubs
-
Inside Trump's 'Alligator Alcatraz': detainees allege abuse in a legal black hole
-
Scientists find surprising sex reversal in Australian birds
-
Taylor Swift sets October release for new album
-
Sinner, Sabalenka sail into Cincinnati quarter-finals
-
Oh carp: UK's Lammy on the hook after fishing with Vance without licence
-
ANITA & ZAHA Introduces Exclusive "Made in France" Natural Cosmetics
-
Sinner shrugs off rain to dispatch Mannarino in Cincinnati
-
Tainted fentanyl blamed for 87 hospital deaths in Argentina
-
Eyeing robotaxis, Tesla hiring New York test car operator
-
NBA approves $6.1bn sale of Boston Celtics
-
PSG beat Tottenham on penalties to win UEFA Super Cup after late comeback
-
Cowboys owner Jones says experimental drug saved him after cancer diagnosis
-
Striking Boeing defense workers turn to US Congress
-
PSG beat Tottenham on penalties to win UEFA Super Cup

Emigrate or waste away: dilemma for Venezuela multiple sclerosis patients
For Venezuelan Jaimar Tuarez, 22, being diagnosed with multiple sclerosis felt like a death sentence in a country unable to provide the drugs she needs to keep her ever-worsening symptoms at bay.
With no means of paying for private treatment or tests, including a spinal tap that costs $800, the psychology student has launched a crowd-funding campaign on GoFundMe that she hopes will allow her to travel abroad in search of medical help.
"For many people the only option is to emigrate," Tuarez, who was diagnosed in 2022, told AFP at her apartment in Charallave, a city some 50 kilometers (31 miles) from Caracas.
"I have to get out of here..." she said through tears. "What will happen with my next relapse? Will I lose the ability to speak? I am 22 years old... what will happen to all my dreams, my plans?"
The plight of Tuarez and an estimated 2,000 other Venezuelans with MS -- a potentially disabling disease of the central nervous system -- underlines the difficulties facing people in need of chronic medication in cash-strapped Venezuela.
There is no cure, but drugs can alleviate MS symptoms.
According to the Inter-American Commission on Human Rights (IAHCR), Venezuela's IVSS social welfare institute stopped providing prescription MS medication years ago.
Venezuela is in the grips of an unprecedented economic crisis, with its once-thriving oil industry all but collapsed and GDP shrinking by 80 percent in eight years of recession until 2022.
Millions have fled in search of a better life elsewhere, many seeking a path to the United States.
- 'We are adrift -
Tuarez has weakened to the point where she can barely stand, forcing her to abandon her psychology studies and quit her job as an online editor that had helped augment the family income.
Now Tuarez and her mother, a stroke survivor, both depend on the meager income of her 72-year-old grandmother, who works at a beauty salon in the capital.
Andres Marcano, a 53-year-old translator diagnosed with MS two decades ago, told AFP his mobility has drastically deteriorated in the last five years after he stopped receiving state-funded medication.
"I find it difficult to speak. I don't walk. I am unable to stand and therefore I move around in a wheelchair," he told AFP via WhatsApp.
The situation "is serious, we are adrift," said another MS sufferer, Maria Eugenia Monagas, 57, who pays privately for treatment thanks to the income of her husband and two children, one of them abroad.
"Many are disabled, or dead, due to a lack of medicines," she said.
The government of President Nicolas Maduro blames the state's failure on US sanctions. But others point to graft allegations against officials from the health ministry and the IVSS in a country with a long history of corruption and mismanagement, according to international observers.
- No options -
Tuarez said her last relapse left her temporarily unable to speak, walk or eat independently.
She was prescribed steroids to ease the symptoms, but could not get any through the IVSS.
In the private sector, the medicines she needs cost as much as $30,000 per year.
Tuarez said she spent Christmas Eve sending out emails to aid organizations in different countries, seeking help to leave the country with her mother, who needs care and cannot be left behind.
So far, she has collected $600 out of her objective of $10,000.
Tuarez is overwhelmed at the thought of leaving behind her family, a beloved dog and two cats, but fears her life is in danger if she does not.
"I wish there were other options, to make a career and live my life (in Venezuela), but there are none," Tuarez said.
Q.Najjar--SF-PST